Synthesis and Biological Activity of Wuweizisu C and Analogs

Author(s): J. B. Chang, Q. Wang, Y. F. Li

Journal Name: Current Topics in Medicinal Chemistry

Volume 9 , Issue 17 , 2009

Become EABM
Become Reviewer


Lignans are widely distributed in nature. The earliest recorded medicinal use of lignans dated back to over 1000 years ago. Lignan-rich plant products were also active ingredients in Chinese and Japanese folk medicines for the treatment of various diseases. The dried root and stem of this plant are listed in the Chinese pharmacopoeia for the treatment of rheumatoid arthritis, gastric, duodenal ulcers and many other diseases. This review highlights synthetic strategies for the Wuweizisu C analogs and the important pharmacological activities as well as therapeutic findings related to the treatment of HBV and other diseases. Notably a significant and ongoing project on Wuweizisu C and its analogs has led to the discovery and development of two potent derivatives α-DDB and BICYCLOL which are currently in clinical trials against HBV, especially in lowering elevated SGPT levels. Further design, synthesis, and evaluation of Wuweizisu C analogs are discussed.

Keywords: Schisandra chinensis, wuweizisu C, analogs, DDB, synthesis, biological activity

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [1660 - 1675]
Pages: 16
DOI: 10.2174/156802609789941933
Price: $65

Article Metrics

PDF: 5